Results 161 to 170 of about 37,898 (281)

Potential diagnostic value of circulating miRNAs in HFrEF and bioinformatics analysis

Heliyon
Background: Few studies have compared the performances of those reported miRNAs as biomarkers for heart failure with reduced EF (HFrEF) in a population at high risk.
Zheng Kuai, Yuanji Ma, Wei Gao, Xiaoxue Zhang, Xiaoyan Wang, Yangli Ye, Xiaoyi Zhang, Jie Yuan   +7 more
doaj   +1 more source

Benefits of renal denervation in HFrEF [PDF]

Nature Reviews Cardiology, 2018
openaire   +3 more sources

MRA use in patients with HFrEF [PDF]

Nature Reviews Cardiology, 2012
openaire   +3 more sources

Angiotensin Receptor Neprilysin Inhibitors in HFrEF: Is This the First Disease Modifying Therapy Drug Class Leading to a Substantial Reduction in Diuretic Need?

, 2021
B Kerr, Rebabonye B. Pharithi, M. Barrett, Carmel Halley, J. Gallagher, Mark Ledwidge, Kenneth McDonald   +6 more
openalex   +1 more source

C73 PICK YOUR THRESHOLD! HOW TO CALCULATE THE ANAEROBIC THRESHOLD TO STRATIFY HEART FAILURE PROGNOSIS: A COMPARISON BETWEEN ABSOLUTE VALUE, PERCENTAGE OF PEAK VO2 OR PERCENTAGE OF PREDICTED MAXIMUM VO2 IN A LARGE MULTICENTER COHORT OF HFREF PATIENTS WHO UNDER [PDF]

, 2022
Scoccia Elisabetta, Massimo Mapelli, Alice Bonomi, Irene Mattavelli, Fabiana De Martino, Carlo Vignati, Paola Gugliandolo, Piergiuseppe Agostoni   +7 more
openalex   +1 more source

122 Real world outcomes of sglt2 inhibition in a hfref population [PDF]

, 2022
Patrick Savage, Daniel McElhatton, M. Campbell, Jordan Bamford, Rebecca Reid, Lana Dixon   +5 more
openalex   +1 more source

Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial. [PDF]

, 2017
Importance: Iron deficiency is present in approximately 50% of patients with heart failure with reduced left ventricular ejection fraction (HFrEF) and is an independent predictor of reduced functional capacity and mortality.
Anstrom, Kevin J, Braunwald, Eugene, Butler, Javed, Desvigne-Nickens, Patrice, Felker, G Michael, Givertz, Michael M, Hernandez, Adrian F, LaRue, Shane J, Lewis, Gregory D, Malhotra, Rajeev, McNulty, Steven E, Redfield, Margaret M, Semigran, Marc J, Shah, Monica R, Smith, Andrew, Tang, W H Wilson, Van Buren, Peter, Whellan, David J   +17 more
core   +1 more source

Development of vericiguat: The first soluble guanylate cyclase (sGC) stimulator launched for heart failure with reduced ejection fraction (HFrEF)

, 2022
Juan Xia, Hui Nan, Lei Tian, Chengyuan Liang, Jie Zhang, Jifang Liu, Jun Wang, Xiaodong Ren, Xiaolin Xie, Kun Wang   +9 more
openalex   +1 more source

Successful treatment with ivabradine in a β-blocker refractory patient with acute decompensated HFrEF [PDF]

, 2022
Tomoko Inoue, Keiji Matsunaga, Waki Kobayashi, Tetsuo Minamino   +3 more
openalex   +1 more source

Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan: The DAPA-HF Trial.

JACC. Heart failure, 2020
S. Solomon, P. Jhund, B. Claggett, P. Dewan, L. Køber, M. Kosiborod, F. Martinez, P. Ponikowski, M. Sabatine, S. Inzucchi, Akshay S. Desai, O. Bengtsson, D. Lindholm, M. Sjostrand, A. Langkilde, J. McMurray   +15 more
semanticscholar   +1 more source